Zantac

GSK Resolves Yet Another Zantac Legal Battle in California, Easing Concerns

by

San Francisco, California – Pharmaceutical company GlaxoSmithKline (GSK) has reached a settlement in yet another lawsuit regarding its popular heartburn medication, Zantac. The lawsuit was filed in California and alleged that the medication caused cancerous tumors in the plaintiff. GSK, based in the United Kingdom, has faced numerous lawsuits across the US concerning the potential link between Zantac and cancer. The settlement comes in the wake of recent studies that found the presence of a probable human carcinogen, NDMA, in ranitidine-based drugs like Zantac. The terms of the settlement were not disclosed, but GSK maintains … Read more

Landmark Hearing Begins as Plaintiffs Allege Cancer Caused by Zantac, Raising Validity Questions for Popular Heartburn Medication

by

Wilmington, Delaware – A Delaware Superior Court judge is set to preside over a case today involving plaintiffs who allege that the popular heartburn medication Zantac caused their cancer. The judge’s main task will be to determine the validity of the methodologies used to establish a connection between this widely-used antacid and certain types of cancer. If the methodologies are deemed valid, the lawsuits against the drug maker will proceed to trial. The lawsuits claim that Zantac, which was discontinued globally by its manufacturer in September 2019 due to concerns about a potentially cancer-causing chemical … Read more